Literature DB >> 31092489

A case of antiphospholipid syndrome presenting cryptogenically as Budd-Chiari syndrome, then fulminantly as Libman-Sacks endocarditis.

Hart A Goldhar1, Paloma O'Meara2, Lana A Castellucci3.   

Abstract

A 58 year-old left-handed woman was transferred to our hospital with an evolving left middle cerebral artery stroke, severe thrombocytopenia and elevated inflammatory markers. She had a history of chronic Budd-Chiari syndrome (BCS) 16 months prior, attributed to a calcified web in the inferior vena cava that was stented. No thrombophilia testing was performed at that time. The current presentation demonstrated dense right-sided facial and arm paresis and neglect. Erythrocyte sedimentation rate and C-reactive protein were elevated, an autoimmune workup was consistent with a new diagnosis of systemic lupus erythematosus and triple-positive antiphospholipid antibodies. A transesophageal echocardiogram demonstrated a vegetation consistent with Libman-Sacks endocarditis (LSE), thought to have embolised to the brain. The patient was treated acutely with steroids, intravenous immunoglobulin and clopidogrel. This case demonstrates an atypical constellation of the antiphospholipid syndrome, with a novel presentation of BCS and LSE, and reinforces the importance of hypercoagulability screening in this population. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  stroke; systemic lupus erythematosus; venous thromboembolism

Mesh:

Year:  2019        PMID: 31092489      PMCID: PMC6536207          DOI: 10.1136/bcr-2018-227450

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

Review 1.  Budd-Chiari syndrome secondary to antiphospholipid syndrome: clinical and immunologic characteristics of 43 patients.

Authors:  G Espinosa; J Font; J C García-Pagan; D Tàssies; J C Reverter; C Gaig; F Cervantes; R Cervera; J Bosch; M Ingelmo
Journal:  Medicine (Baltimore)       Date:  2001-11       Impact factor: 1.889

2.  International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).

Authors:  S Miyakis; M D Lockshin; T Atsumi; D W Branch; R L Brey; R Cervera; R H W M Derksen; P G DE Groot; T Koike; P L Meroni; G Reber; Y Shoenfeld; A Tincani; P G Vlachoyiannopoulos; S A Krilis
Journal:  J Thromb Haemost       Date:  2006-02       Impact factor: 5.824

3.  Vascular disorders of the liver.

Authors:  Laurie D DeLeve; Dominique-Charles Valla; Guadalupe Garcia-Tsao
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

Review 4.  Liver cirrhosis in hepatic vena cava syndrome (or membranous obstruction of inferior vena cava).

Authors:  Santosh Man Shrestha
Journal:  World J Hepatol       Date:  2015-04-28

5.  Primary Budd-Chiari syndrome: outcome of endovascular management for suprahepatic venous obstruction.

Authors:  Byung-Boong Lee; Leonel Villavicencio; Young Wook Kim; Young Soo Do; Kwang Chul Koh; Hyo Keun Lim; Jae Hoon Lim; Keung Whan Ahn
Journal:  J Vasc Surg       Date:  2006-01       Impact factor: 4.268

Review 6.  Diagnosis and Management of the Antiphospholipid Syndrome.

Authors:  David Garcia; Doruk Erkan
Journal:  N Engl J Med       Date:  2018-05-24       Impact factor: 91.245

7.  Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients.

Authors:  Ricard Cervera; Jean-Charles Piette; Josep Font; Munther A Khamashta; Yehuda Shoenfeld; María Teresa Camps; Soren Jacobsen; Gabriella Lakos; Angela Tincani; Irene Kontopoulou-Griva; Mauro Galeazzi; Pier Luigi Meroni; Ronald H W M Derksen; Philip G de Groot; Erika Gromnica-Ihle; Marta Baleva; Marta Mosca; Stefano Bombardieri; Frédéric Houssiau; Jean-Christophe Gris; Isabelle Quéré; Eric Hachulla; Carlos Vasconcelos; Beate Roch; Antonio Fernández-Nebro; Marie-Claire Boffa; Graham R V Hughes; Miguel Ingelmo
Journal:  Arthritis Rheum       Date:  2002-04

8.  Membranous obstruction of the inferior vena cava and extensive bone marrow necrosis associated with catastrophic antiphospholipid syndrome.

Authors:  A C Spyropoulos
Journal:  J Clin Rheumatol       Date:  1999-10       Impact factor: 3.517

9.  Libman-Sacks endocarditis in systemic lupus erythematosus: prevalence, associations, and evolution.

Authors:  Ioannis Moyssakis; Maria G Tektonidou; Vassilios A Vasilliou; Michael Samarkos; Vassilios Votteas; Haralampos M Moutsopoulos
Journal:  Am J Med       Date:  2007-07       Impact factor: 4.965

  9 in total
  1 in total

Review 1.  The digestive system involvement of antiphospholipid syndrome: pathophysiology, clinical characteristics, and treatment strategies.

Authors:  Jin Zhang; Cheng Li; Xiaorong Han; Zhongbo Chen; Binay Kumar Adhikari; Yinghui Wang; Yonggang Wang; Jian Sun
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.